Asymmetric synthesis of (R)-2-[3-(methoxymethoxy)propyl]- 3,3-diphenyl-1-tosyl-1,3-azasilinan-6-one

Azasilanes have excellent bioactivities; however, asymmetric synthesis of azasilinan-6-one with a substitution at the second potion has been investigated very little. In this paper, (R)-2-[3-(methoxymethoxy)propyl] -3,3-diphenyl-1-tosyl-1,3-azasilinan-6-one was successfully synthesized. | JOURNAL OF SCIENCE OF HNUE Chemical and Biological Sci. 2014 Vol. 59 No. 9 pp. 3-10 This paper is available online at http ASYMMETRIC SYNTHESIS OF R -2- 3- METHOXYMETHOXY PROPYL - 3 3-DIPHENYL-1-TOSYL-1 3-AZASILINAN-6-ONE Duong Quoc Hoan1 and Scott McN. Sieburth2 1 Faculty of Chemistry Hanoi National University of Education 2 Department of Chemistry Temple University the United States of America Abstract. Azasilanes have excellent bioactivities however asymmetric synthesis of azasilinan-6-one with a substitution at the second potion has been investigated very little. In this paper R -2- 3- methoxymethoxy propyl -3 3-diphenyl-1-tosyl-1 3-azasilinan-6-one was successfully synthesized. The chiral center of silylsulfinamide was prepared by the addition of silyl lithium to R -Davis chiral sulfinimine. Cyclization of δ-amino carboxylic acid gave 1 3-azasilinan-6-one that can be an important product to synthesize 2-substituted 1 3-azasilinan rings. Structures of all new compounds were confirmed by IR 1 H and 13 C-NMR along with the exact mass. Keywords Synthesis R -2- 3- methoxymethoxy propyl -3 3-diphenyl-1-tosyl-1 3- -azasilinan-6-one IR 1 H and 13 C-NMR. 1. Introduction Nitrogen-containing heterocycles constitute structural frameworks in a plethora of pharmaceuticals and alkaloids and are essential components of the pharmacophore 2 3 6 . In recent years there has been an interest in the preparation of heterocycles in which one of the ring carbons has been replaced by silicon atoms. A few bioactive silicon-nitrogen heterocycles have thus far been synthesized and screened for bioactivity. For example the dopamine receptor antagonist silahaloperidol 1 Figure 1 displays improved selectivity compared to haloperidol. Furthermore its metabolic fate in human liver microsomas does not produce a silicon analogue of the neurotoxic metabolite HPP Hereditary pyropoikilocytosis which is responsible for the severe side effects of haloperidol 4 . Other heterocyclic .

Không thể tạo bản xem trước, hãy bấm tải xuống
TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN
TÀI LIỆU MỚI ĐĂNG
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.